gabexate has been researched along with Anterior Circulation Transient Ischemic Attack in 2 studies
Gabexate: A serine proteinase inhibitor used therapeutically in the treatment of pancreatitis, disseminated intravascular coagulation (DIC), and as a regional anticoagulant for hemodialysis. The drug inhibits the hydrolytic effects of thrombin, plasmin, and kallikrein, but not of chymotrypsin and aprotinin.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ito, M | 1 |
| Yanamoto, H | 1 |
| Kikuchi, H | 1 |
| Okamoto, S | 1 |
2 other studies available for gabexate and Anterior Circulation Transient Ischemic Attack
| Article | Year |
|---|---|
[Experimental vasospasms--significance of oxyhemoglobin, fibrin degradation products and breakdown products of white ghost in the pathogenesis of cerebral vasospasms. Treatment of vasospasms with gabexate mesilate and diphenhydramine (author's transl)].
Topics: Animals; Diphenhydramine; Dogs; Fibrin Fibrinogen Degradation Products; Gabexate; Guanidines; Haptog | 1980 |
Effects of protease inhibitor and immunosuppressant on cerebral vasospasm after subarachnoid hemorrhage in rabbits.
Topics: Animals; Benzamidines; Betamethasone; Cyclosporine; Drug Administration Schedule; Gabexate; Guanidin | 1994 |